Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA on bisphenol A

This article was originally published in The Gray Sheet

Executive Summary

Agency's decision to restrict its initial toxicity analysis of bisphenol A (BPA) to food-contact applications such as infant formula packaging "severely limits the usefulness" of the agency's draft 1assessment issued in August, says a subcommittee to FDA's Science Board in a 2report posted online Oct. 29. The report says FDA should have considered the "totality of exposures," including from medical devices used in the neonatal intensive care unit, to guide more accurate calculations. The observation is one of several critiques lodged at FDA's assessment, which the subcommittee says overlooks potentially informative data and comes to questionable conclusions about the safety margins for BPA levels in food packaging. FDA has said it plans to develop a separate assessment of BPA in medical products (3"The Gray Sheet" Oct. 20, 2008, In Brief). The subcommittee presented the report at an Oct. 31 Science Board meeting
Advertisement

Related Content

FDA seeks data on BPA-containing devices
Advertisement
UsernamePublicRestriction

Register

MT026742

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel